oral glp-1 medications fda approved Approved: Orforglipron (Foundayo) — Drug • FDA for chronic weight management • Indicated for obesity and overweight with comorbidities • Oral, once-daily GLP-1 receptor agonist • First non-peptide Comparing Ozempic, Wegovy and Other

Hyperammonemic encephalopathy in multiple myeloma

A 2025 review showed that 35 preclinical trials and one clinical study have been completed with BPC-157.[ref] Lets take a look at how this plays out in specific injuries and wounds

Treat low blood sugar (below 4 mmol/L) with 15-20g of fast-acting carbohydrate (like glucose tablets or fruit juice), followed by a longer-acting carbohydrate snack

Another ingredient - Vitamin C in Reload electrolyte drink benefits in reducing muscle soreness and fatigue

Universal sample preparation method for proteome analysis

Dive into this new analysis and discover how we can make healthcare more accessible for everyone